dailysun.net.au

Nasal-spraying LiveSpo NAVAX: Probiotics of the next generation for respiratory infections

  • Written by Daily Sun
HANOI, VIETNAM - Media OutReach - 15 August 2022 - On July 20nd, the Scientific Reports journal (the Nature) officially annouced a break-through research on using LiveSpo NAVAX probiotic spores in nasal spray form to support the treatment of acute respiratory infections in children infected with respiratory syncytial virus (RSV) [1]

Photo-1-.png

 Respiratory syncytial virus (RSV) is a leading cause of Acute Respiratory Tract Infections (ARTIs) in young children.

More Articles ...

  1. Four HKTDC August fairs and ICMCM close on a High Note
  2. Jaguar TCS Racing Team Forges Ahead to Seoul for the 2022 Formula E World Championship E-Prix Races
  3. HyD holds "Building and Maintaining Highway Infrastructure through Innovation in Highways Department" exhibition in celebration of HKSAR 25th anniversary
  4. Appier continues its strong growth momentum and raises full-year guidance second quarter in a row
  5. Virtuos Bolsters Southeast Asian Presence With Launch of Game Development Studio in Kuala Lumpur
  6. Schneider Electric makes steady progress toward 2025 sustainability targets
  7. Crypto Exchange Bybit Branches Out in India with Learning and Earning Campaign
  8. New Times Energy issues profit alert and expects to post a profit of HK$200 to HK$220 million for first half of 2022
  9. Insilico Medicine Announces New Investment Led by Aramco-backed Prosperity7 Ventures, bringing the total Series D Financing to $95 Million
  10. eWTP Arabia Capital ranks among Top 50 Best Performers and Rising Stars in China